Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.

The names on this page are hidden. Create a free account and they fill in. No card, and every figure, date and source on this page is public either way.

Companies / A••••••

A••••••

Stage unknownUSa••••••.bio
Facts
Year of incorporation
unknown
Revenue range (Form D)
unknown
Rounds on record
2
Disclosed raised
$33.0Msum of rounds with a disclosed amount only
Named investors
4
Financing history
2 rounds
  1. Mar 4, 2026
    Funding round · $9.0M (disclosed)
    Fact Press release wires (Business Wire, PR Newswire, GlobeNewswire public RSS) · “A•••••• Secures Additional $9 Million in Expanded BioMaP-Consortium Project Agreement to Onshore Pharmaceutical Supply Chains”
  2. Jan 27, 2026
    Series C · $24.0M (disclosed)
    A•••• K• (lead)H••••• I••••••••• C••••••••• (participant)G••••• H••••• I••••••••• C••••••••• (participant)
    Fact Press release wires (Business Wire, PR Newswire, GlobeNewswire public RSS) · “A•••••• Raises Additional $24 Million to Complete Series C Financing, Bringing Total Funds Raised to More than $175 Million Over Past Year”
Investors on record
4 edges
People
0 officers, 0 directors
No officer or director on record.
Timeline
2
  1. Mar 4, 2026
    A•••••• announced Funding round of $9,000,000
    Round announced Fact Press release wires (Business Wire, PR Newswire, GlobeNewswire public RSS)
  2. Jan 27, 2026
    A•••••• announced Series C of $24,000,000, led by A•••• K•
    Round announced Fact Press release wires (Business Wire, PR Newswire, GlobeNewswire public RSS)
Evidence
4 observations
Every observation on this company